Company intelligence / Profile preview

Conversa

Portland, Oregon, United States

Ownership: Private
Employees: ~41
Development stage: Other

Overview

Conversa Health developed and commercialized an automated virtual care and triage platform using AI-enabled conversational technology, successfully deployed for chronic disease management, perioperative care, oncology, and COVID-19 patient monitoring at scale in partnership with leading healthcare systems. The company was acquired by Amwell in 2021 to expand Amwell's virtual care capabilities[3][2][4].

Therapeutic areas: CardiovascularEndocrinologyRheumatologyPulmonologyWomen's HealthInfectious DiseasesOtherOncology
Modalities: DeviceNon-pharmacological therapy
Industry: Digital Health Medical Devices

Partnerships

Northwell HealthUCSF HealthUNC HealthUniversity HospitalsPrisma HealthSCL Health

Beyond the preview

Go deeper on Conversa.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Conversa.

Explore the full profile